| Literature DB >> 29532188 |
Jichen Bao1,2, Mingtao Huang1,2, Dina Petranovic1,2, Jens Nielsen3,4,5.
Abstract
The yeast Saccharomyces cerevisiae is widely used as a cell factory to produce recombinant proteins. However, S. cerevisiae naturally secretes only a few proteins, such as invertase and the mating alpha factor, and its secretory capacity is limited. It has been reported that engineering protein anterograde trafficking from the endoplasmic reticulum to the Golgi apparatus by the moderate overexpression of SEC16 could increase recombinant protein secretion in S. cerevisiae. In this study, the retrograde trafficking in a strain with moderate overexpression of SEC16 was engineered by overexpression of ADP-ribosylation factor GTP activating proteins, Gcs1p and Glo3p, which are involved in the process of COPI-coated vesicle formation. Engineering the retrograde trafficking increased the secretion of α-amylase but did not induce production of reactive oxygen species. An expanded ER membrane was detected in both the GCS1 and GLO3 overexpression strains. Physiological characterizations during batch fermentation showed that GLO3 overexpression had better effect on recombinant protein secretion than GCS1 overexpression. Additionally, the GLO3 overexpression strain had higher secretion of two other recombinant proteins, endoglucanase I from Trichoderma reesei and glucan-1,4-α-glucosidase from Rhizopus oryzae, indicating overexpression of GLO3 in a SEC16 moderate overexpression strain might be a general strategy for improving production of secreted proteins by yeast.Entities:
Keywords: COPI vesicle; GLO3; Protein secretion; Retrograde trafficking; Saccharomyces cerevisiae
Year: 2018 PMID: 29532188 PMCID: PMC5847638 DOI: 10.1186/s13568-018-0571-x
Source DB: PubMed Journal: AMB Express ISSN: 2191-0855 Impact factor: 3.298
Plasmids and strains used in this study
| Name | Description | References |
|---|---|---|
| Plasmids | ||
| CPOTud | TPI promoter and terminator from | Liu et al. ( |
| pAlphaAmyCPOT | α factor leader with α-amylase gene inserted into CPOTud | Liu et al. ( |
| pAlphaTrEGCPOT | α factor leader with endoglucanase I gene inserted into CPOTud | Bao et al. ( |
| pCP-aGLA | α factor leader with glucan 1,4-α-glucosidase gene inserted into CPOTud | Huang et al. ( |
| Strains | ||
| CEN.PK530-6CK | Bao et al. ( | |
| YIGS16 | CEN.PK530-6CK with pAlphaAmyCPOT | Bao et al. ( |
| YIGCS1 | YIGS16 | This study |
| YIGLO3 | YIGS16 | This study |
| AACK | Bao et al. ( | |
| AACK-GCS1 | AACK | This study |
| AACK-GLO3 | AACK | This study |
| YIGLO3GCS1 | YIGS16 | This study |
| CEN.PK530-6CK + EG | CEN.PK530-6CK with pAlphaTrEGCPOT | This study |
| CEN.PK530-6CK + AGL | CEN.PK530-6CK with pCP-aGLA | This study |
| GLO3 + EG | CEN.PK530-6CK | This study |
| GLO3 + AGL | CEN.PK530-6CK | This study |
Fig. 1Overexpression of GCS1 or GLO3 by promoter replacement in the SEC16-overexpression strain (YIGS16) has a positive effect on α-amylase secretion. a Constructions of the vesicle trafficking engineering strains. SEC16 is involved in COPII vesicle formation; GCS1 and GLO3 are involved in COPI vesicle formation. b The titer and biomass of YIGS16, YIGCS1 and YIGLO3. c The titer and biomass of AACK, AACK-GCS1 and AACK-GLO3. *P < 0.05; **P < 0.01; ***P < 0.001. Measurements are reported as the average value ± standard deviation from independent triplicates
Fig. 2The amounts of ER membrane of strains a YIGS16, YIGCS1 and YIGLO3. b AACK, AACK-GCS1 and AACK-GLO3 using ER-Tracker Blue-White DPX. The ER membrane changes were quantified by their fluorescence intensity. *P < 0.05; ***P < 0.001. Measurements are reported as the average value ± standard deviation from independent triplicates
Fig. 3Batch fermentation of the strain YIGS16, YIGCS1 and YIGLO3. The time course of a the biomass and b the α-amylase titer. c The titer/biomass ratio and d the percentage of intracellular α-amylase of the three strains at five different time points. Measurements are reported as the average value ± standard deviation from independent triplicates
Physiological parameters of YIGS16, YIGCS1 and YIGLO3
| Strain | μmax | rS | rp |
| rE | rG |
|---|---|---|---|---|---|---|
| YIGS16 | 0.194 ± 0.003 | 1.21 ± 0.01 | 158.12 ± 7.80 | 130.47 ± 4.98 | 0.147 ± 0.002 | 0.253 ± 0.005 |
| YIGCS1 | 0.226 ± 0.004*** | 1.16 ± 0.01** | 154.36 ± 1.74 | 128.93 ± 2.48 | 0.147 ± 0.005 | 0.261 ± 0.007 |
| YIGLO3 | 0.217 ± 0.002** | 1.25 ± 0.03 | 182.90 ± 7.31* | 145.92 ± 5.76* | 0.165 ± 0.001*** | 0.231 ± 0.006* |
μ maximum specific growth rate (h−1) on glucose, r specific glucose uptake rate (g/(g-DCW)/h), r specific α-amylase production rate (U/(g-DCW)/h) on glucose, Y yield of α-amylase from glucose (U/g), r specific ethanol production rate (g/(g-DCW)/h), r specific glycerol production rate (g/(g-DCW)/h)
“*” represents the statistical significance of the difference between the parameters of YIGCS1 or YIGLO3 and those of YIGS16. *P < 0.05; **P < 0.01; ***P < 0.001. Measurements are reported as the average value ± standard deviation from independent triplicates
Fig. 4Secretion of two recombinant proteins, endoglucanase and glucan 1,4-α-glucosidase, in the reference strain and GLO3-overexpression strain. ***P < 0.001 Measurements are reported as the average value ± standard deviation from independent quadruplicates